Stocks · Health care · Medicinal Chemicals & Botanical Products

Definium Therapeutics, Inc.

DFTX Clue Score37
United States Fiscal year ends December CIK 0001813814 Results filed 6 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
David W Gryska
5 Dec 2024
Director
Buy
2,500
$7.17
$17.93K
David W Gryska
23 Aug 2024
Director
Buy
3,500
$5.98
$20.93K
Robert Barrow
20 Aug 2024
Chief Executive Officer
Buy
500
$6.12
$3.06K
Robert Barrow
19 Aug 2024
Chief Executive Officer
Buy
500
$6.31
$3.16K

What was left out

Form 4 filings counted 160
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 40
Sales straight out of an exercise 0
Sales at will 41
Transactions with no price 0
Shares from compensation/vesting 12,496,357
Sales filed before the plan box existed 25
History held since 19 Jan 2022